The inflammasome, autoinflammatory diseases, and gout

Joint Bone Spine - Tập 74 - Trang 571-576 - 2007
Virginie Pétrilli1, Fabio Martinon2
1Department of Biochemistry, Lausanne University, Lausanne, Switzerland
2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA

Tài liệu tham khảo

Galon, 2000, TNFRSF1A mutations and autoinflammatory syndromes, Curr Opin Immunol, 12, 479, 10.1016/S0952-7915(00)00124-2 McDermott, 1999, Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes, Cell, 97, 133, 10.1016/S0092-8674(00)80721-7 McGonagle, 2006, A proposed classification of the immunological diseases, PLoS Med, 3, e297, 10.1371/journal.pmed.0030297 Stojanov, 2005, Familial autoinflammatory diseases: genetics, pathogenesis and treatment, Curr Opin Rheumatol, 17, 586, 10.1097/bor.0000174210.78449.6b Nemunaitis, 1994, Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure, Bone Marrow Transplant, 14, 583 Nemunaitis, 1994, Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia, Blood, 83, 3473, 10.1182/blood.V83.12.3473.3473 Crown, 1993, Interleukin-1: biological effects in human hematopoiesis, Leuk Lymphoma, 9, 433, 10.3109/10428199309145750 McKean, 1985, The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones, J Immunol, 135, 3205, 10.4049/jimmunol.135.5.3205 Tamaru, 1998, Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo, Arterioscler Thromb Vasc Biol, 18, 1292, 10.1161/01.ATV.18.8.1292 Sutton, 1997, Endothelial structural integrity is maintained during endotoxic shock in an interleukin-1 type 1 receptor knockout mouse, Shock, 7, 105, 10.1097/00024382-199702000-00006 Furie, 1989, Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha, J Immunol, 143, 3309, 10.4049/jimmunol.143.10.3309 Dinarello, 2005, Interleukin-1beta, Crit Care Med, 33, S460, 10.1097/01.CCM.0000185500.11080.91 Feng, 1995, Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide, J Clin Invest, 95, 1669, 10.1172/JCI117842 Pang, 1997, Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells, Br J Pharmacol, 121, 579, 10.1038/sj.bjp.0701152 Dinarello, 2002, The IL-1 family and inflammatory diseases, Clin Exp Rheumatol, 20, S1 Campbell, 1988, Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator, Biochim Biophys Acta, 967, 183, 10.1016/0304-4165(88)90008-6 Dayer, 1986, Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells, J Clin Invest, 77, 645, 10.1172/JCI112350 Verbruggen, 2006, Chondroprotective drugs in degenerative joint diseases, Rheumatology (Oxford), 45, 129, 10.1093/rheumatology/kei171 Kostura, 1989, Identification of a monocyte specific pre-interleukin 1 beta convertase activity, Proc Natl Acad Sci U S A, 86, 5227, 10.1073/pnas.86.14.5227 Watanabe, 2007, Activation of the IL-1b-processing inflammasome is involved in contact hypersensitivity, J Invest Dermatol, 10.1038/sj.jid.5700819 Black, 1989, Activation of interleukin-1 beta by a co-induced protease, FEBS Lett, 247, 386, 10.1016/0014-5793(89)81376-6 Thornberry, 1991, Mechanism-based inactivation of alanine racemase by 3-halovinylglycines, J Biol Chem, 266, 21657, 10.1016/S0021-9258(18)54687-1 Dinarello, 2003, Interleukin-18 and host defense against infection, J Infect Dis, 187, S370, 10.1086/374751 Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 Martinon, 2007, Inflammatory caspases and inflammasomes: master switches of inflammation, Cell Death Differ, 14, 10, 10.1038/sj.cdd.4402038 Vasilakos, 1995, IL-1 beta converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line, J Immunol, 155, 3433, 10.4049/jimmunol.155.7.3433 Li, 1995, Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock, Cell, 80, 401, 10.1016/0092-8674(95)90490-5 Kuida, 1995, Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme, Science, 267, 2000, 10.1126/science.7535475 Martinon, 2002, The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta, Mol Cell, 10, 417, 10.1016/S1097-2765(02)00599-3 Tschopp, 2003, NALPs: a novel protein family involved in inflammation, Nat Rev Mol Cell Biol, 4, 95, 10.1038/nrm1019 Agostini, 2004, NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder, Immunity, 20, 319, 10.1016/S1074-7613(04)00046-9 Sutterwala, 2006, Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1, Immunity, 24, 317, 10.1016/j.immuni.2006.02.004 Mariathasan, 2006, Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, 40, 228, 10.1038/nature04515 Kanneganti, 2006, Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3, Nature, 440, 233, 10.1038/nature04517 Kastner, 2005, Hereditary periodic Fever syndromes, Hematology Am Soc Hematol Educ Program, 74, 10.1182/asheducation-2005.1.74 Masters, 2006, Recent advances in the molecular pathogenesis of hereditary recurrent fevers, Curr Opin Allergy Clin Immunol, 6, 428, 10.1097/ACI.0b013e3280109b57 Prieur, 1987, A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients, Scand J Rheumatol Suppl, 66, 57, 10.3109/03009748709102523 Feldmann, 2002, Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes, Am J Hum Genet, 71, 198, 10.1086/341357 Hoffman, 2001, Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome, Nat Genet, 29, 301, 10.1038/ng756 Mikuls, 2006, New insights into gout epidemiology, Curr Opin Rheumatol, 18, 199, 10.1097/01.bor.0000209435.89720.7c Wu, 1989, Urate oxidase: primary structure and evolutionary implications, Proc Natl Acad Sci U S A, 86, 9412, 10.1073/pnas.86.23.9412 Wu, 1992, Two independent mutational events in the loss of urate oxidase during hominoid evolution, J Mol Evol, 34, 78, 10.1007/BF00163854 Choi, 2005, Gout: epidemiology and lifestyle choices, Curr Opin Rheumatol, 17, 341 Choi, 2005, Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study, Arch Intern Med, 165, 742, 10.1001/archinte.165.7.742 Terkeltaub, 1991, Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation, Arthritis Rheum, 34, 894, 10.1002/art.1780340716 Hachicha, 1995, Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis, J Exp Med, 182, 2019, 10.1084/jem.182.6.2019 di Giovine, 1991, Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution, J Clin Invest, 87, 1375, 10.1172/JCI115142 Niel, 2006, Colchicine today, Joint Bone Spine, 73, 672, 10.1016/j.jbspin.2006.03.006 Shi, 2003, Molecular identification of a danger signal that alerts the immune system to dying cells, Nature, 425, 516, 10.1038/nature01991 Martinon, 2006, Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, 440, 237, 10.1038/nature04516 Martinon, 2006, Gout: new insights into an old disease, J Clin Invest, 116, 2073, 10.1172/JCI29404 Chen, 2006, MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals, J Clin Invest, 116, 2262, 10.1172/JCI28075 Hoffman, 2004, Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist, Lancet, 364, 1779, 10.1016/S0140-6736(04)17401-1 Hawkins, 2004, Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra, Arthritis Rheum, 50, 607, 10.1002/art.20033 Hawkins, 2003, Interleukin-1-receptor antagonist in the Muckle–Wells syndrome, N Engl J Med, 348, 2583, 10.1056/NEJM200306193482523 So, 2007, A pilot study of IL-1 inhibition by anakinra in acute gout, Arthritis Res Ther, 9, R28, 10.1186/ar2143